Spikevax 2024 25% Of. It is made using the same messenger. Market share to date increased to 45% from 36% in 2022.
Mrna, +0.25% on tuesday announced a reorganization designed to sharpen the company’s focus on driving sales of covid vaccine spikevax. Another preprint study from the united states, contracted by the vaccine manufacturer moderna, reports a vaccine effectiveness of 30.4% (95% ci: